Ochre Bio is a brand that is dedicated to tackling the most pressing liver health challenges. Their mission is to develop innovative therapies that address the complexities of liver disease. With a focus on deep phenotyping livers at scale, Ochre Bio is committed to increasing the donor liver supply and reducing complications related to cirrhosis.

Using cutting-edge computational and multi-omic technologies, they have created a next-generation platform for solving liver disease. By designing precision RNA therapies, Ochre Bio aims to reprogram and regenerate human livers outside the body. This groundbreaking approach has the potential to revolutionize the field of liver disease and greatly benefit patients.

Led by a team of experts, including renowned hepatologists and genetics professors, Ochre Bio is at the forefront of innovative research and is dedicated to advancing the understanding and treatment of liver disease